David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 10.34% |
| 2 | Technology | 9.79% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.68% |
| 5 | Financials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KLXI
851
DELISTED
KLX Inc.
KLXI
| $12M | 0.02% |
370,012
+361,473
| +4,233% | +$12.1M |
|
|
EMC
852
PUT
DELISTED
EMC CORPORATION
EMC
| $12M | 0.02% |
470,000
+379,400
| +419% | +$10.5M |
|
853
Kohl's
KSS
$2.08B
| $12M | 0.02% |
153,205
+142,551
| +1,338% | +$9.7M |
|
|
FTR
854
DELISTED
Frontier Communications Corp.
FTR
| $12M | 0.02% |
113,299
-158,318
| -58% | -$17.5M |
|
855
Smith & Wesson
SWBI
$612M
| $11.9M | 0.02% |
1,219,890
+856,618
| +236% | +$8.19M |
|
856
Kaiser Aluminum
KALU
$2.49B
| $11.9M | 0.02% |
154,757
+143,957
| +1,333% | +$10.6M |
|
|
MLNX
857
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $11.9M | 0.02% |
261,981
+218,463
| +502% | +$9.99M |
|
|
S
858
DELISTED
Sprint Corporation
S
| $11.8M | 0.02% |
2,500,000
-5,014,018
| -67% | -$23.6M |
|
859
Neurocrine Biosciences
NBIX
$15.6B
| $11.8M | 0.02% |
297,292
-72,178
| -20% | -$2.58M |
|
|
Y
860
DELISTED
Alleghany Corp
Y
| $11.8M | 0.02% |
24,240
-388
| -2% | -$181K |
|
861
CALL
Morgan Stanley
MS
$336B
| $11.8M | 0.02% |
330,600
-344,600
| -51% | -$12.4M |
|
862
CALL
Equinix
EQIX
$104B
| $11.8M | 0.02% |
50,600
-300
| -0.6% | -$67.9K |
|
|
PMC
863
DELISTED
PharMerica Corporation
PMC
| $11.8M | 0.02% |
417,967
-88,071
| -17% | -$2.19M |
|
864
CALL
Norfolk Southern
NSC
$79.3B
| $11.8M | 0.02% |
114,200
| – | – |
|
865
ArcelorMittal
MT
$54.8B
| $11.7M | 0.02% |
544,622
+233,004
| +75% | +$5.47M |
|
866
CALL
RTX Corp
RTX
$282B
| $11.7M | 0.02% |
158,900
-14,619
| -8% | -$1.09M |
|
867
Omeros
OMER
$1.4B
| $11.7M | 0.02% |
531,292
+128,052
| +32% | +$2.92M |
|
|
TMH
868
DELISTED
Team Health Holdings Inc
TMH
| $11.7M | 0.02% |
+200,018
| New | +$11.3M |
|
869
Fluor
FLR
$6.86B
| $11.7M | 0.02% |
204,307
+142,527
| +231% | +$8.1M |
|
870
CALL
CVS Health
CVS
$120B
| $11.6M | 0.02% |
112,700
+17,200
| +18% | +$1.74M |
|
|
MNDT
871
PUT
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $11.6M | 0.02% |
296,200
-74,500
| -20% | -$2.88M |
|
872
PUT
Ross Stores
ROST
$77.5B
| $11.6M | 0.02% |
220,600
-101,400
| -31% | -$5.02M |
|
873
PUT
American International
AIG
$40.5B
| $11.6M | 0.02% |
211,900
-32,000
| -13% | -$1.72M |
|
|
CVT
874
DELISTED
CVENT, INC.
CVT
| $11.6M | 0.02% |
413,989
-16,514
| -4% | -$453K |
|
875
Banco Santander Chile
BSAC
$17B
| $11.6M | 0.02% |
534,081
-88,002
| -14% | -$1.78M |
|
Similar funds
David Shaw's Q1 2015 Portfolio in Review
As of Q1 2015, David Shaw held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 10% of assets, up from 8.6% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in SPDR Gold Trust worth $231M.
- David Shaw's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- David Shaw's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- David Shaw fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- David Shaw's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- David Shaw opened 448 new positions and closed 828 in Q1 2015.
- David Shaw's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.